Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Bionano Genomics, Inc.

Bionano provides OGM systems, software solutions, and support for genomic variation analysis across clinical care, research, and therapeutics.

Bionano

Bionano | 29,438 followers on LinkedIn. Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. Our mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software. We offer OGM solutions for applications across basic, translational and clinical research.

Senior Business Systems Analyst - Dynamics 365 Finance and Supply Chain Solutions Architect

Tod Heath

David Glick

Erik Holmlin

Kishor Bhakta

Transform with us. #Bionano optical genome mapping tools and software enable researchers to understand the structural variants within the human genome like never before. With #OGM at our fingertips, we can have a more comprehensive view of specific variations that may impact translational research, which can help to elevate health and wellness for all people. #GenomeMapping Will you join us?

📣 Big news in cytogenomics! The 2024 edition of the International System for Human Cytogenomic Nomenclature (ISCN) has just been released, featuring a new standardized naming convention for #OGM . This groundbreaking inclusion marks a major step forward in establishing OGM as an essential tool in the cytogenomic community. We’re especially thrilled to see OGM data featured prominently on the cover, showcasing a circos plot of translocations detected in a leukemia sample. This visual not only symbolizes the growing adoption of OGM in advanced genomic analysis but also underscores its crucial role in driving impactful discoveries in complex diseases. See our very own Alka Chaubey and Mark Oldakowski with the new ISCN book in hand, representing our commitment to leading the way in next-generation genomics! 🧬

We are excited to connect with you in Rome, Italy, at the 31st Annual Congress of the European Society of Gene & Cell Therapy (ESGCT) from October 22-25, 2024. ESGCT brings together leading scientists in gene and cell therapy from across the globe. 🚀 If you are curious about how OGM can be used in cell and gene therapy, visit us at booth #B15 to chat with our experts!

We're so excited to head to St. Louis, Missouri for the upcoming CANCER GENOMICS CONSORTIUM Annual Meeting, which will take place August 4-7, 2024. If you're planning to attend, please stop by Booth #16 to talk to our team about the latest innovations to our #OGM workflow, designed to advance your oncology research capabilities. You also won't want to miss scientific poster presentations from researchers at Vancouver General Hospital and Dartmouth Hitchcock Medical Center and Clinics covering OGM's utility in hematologic cancer research. Finally, Phillip Michaels from Harvard Medical School and Brigham and Women's Hospital will present the latest data from a multi-site study comparing OGM to classical cytogenetic methods for myeloid malignancies. Scroll to check out details, and for more information, please visit: https://lnkd.in/gTE7siv2 #cancerresearch #bloodcancer #scientificconference #cancergenomics #genomics #CGCANNUAL2024

Unlock new insights in blood cancer research with optical genome mapping! Hematological malignancies are a complex group of blood cancers. With classical cytogenetic methods, researchers cannot detect or resolve many relevant chromosomal abnormalities in these samples. 💻 Join us for an exclusive live webinar hosted by A-Plus Clinical Laboratories, where experts will discuss how #OGM can overcome the limitations of classical methods and transform the characterization of hematological malignancies. 📅 Date: July 25, 2024 🕐 Time: 1:00 PM CAT Don't miss out on this opportunity to enhance your understanding and stay ahead in the field. Learn more and register here: https://lnkd.in/g9X6ra3i A-Plus Clinical Laboratories

We're excited to announce that #Bionano optical genome mapping solutions are now available in even more Latin American countries than ever before, through new distribution partner Rochem Biocare de Panamá . Researchers in Chile, Ecuador, Peru, Uruguay, and Panama can now utilize #OGM to transform their cytogenetic workflows! If you'd like to learn more about how OGM can elevate your research capabilities in cancer, genetic disease, and cell and gene therapy applications, please contact us: https://lnkd.in/eAG5jjZ6

At last week's International Society for Stem Cell Research annual conference, Bionano team members and customers shared compelling data showing OGM's utility for cell and gene therapy applications. The Innovation Showcase, featuring Drs. Jeanne Loring, Lucia Gallego Villarejo, and Alicia Bertolotti, covered the use of OGM to assess genome integrity and monitor genomic instability in cell culture maintenance, and to reveal genomic alterations upon gene editing in hiPSCs. The presenters noted that OGM is a highly accurate method for the detection of genome-wide structural changes at higher resolution than conventional chromosome analysis. If you'd like to learn how OGM can help you overcome limitations in cell bioprocessing workflows, please visit: https://lnkd.in/dZJqRdSb . #ISSCR2024 #ISSCR24 #cellandgenetherapy #stemcellresearch #cellbioprocessing #OGM #Bionano

Optical genome mapping ( #OGM ) was well-represented among the many scientific presentations and posters at the recent ESHG European Society of Human Genetics conference in Berlin. Global presenters highlighted OGM's ability to detect structural variants relevant to understanding the genetic basis of rare diseases, with data showing how researchers' use of OGM helped solve long-standing genetic mysteries. For more on the insights and findings shared at #ESHG2024 , please check out our latest blog post: https://lnkd.in/g58rSK4T #raredisease #rarediseaseresearch #geneticdisorders #scientificconferences #ESHG24 #geneticresearch

The Bionano team is excited to travel to Hamburg, Germany this week for #ISSCR2024 ! If you're planning to attend, check out all of the terrific scientific content you won't want to miss that will highlight optical genome mapping's utility for cell and gene therapy research! For more information, visit https://lnkd.in/gVzzYwgU or stop by booth #911 to connect with our team! International Society for Stem Cell Research #cellandgenetherapy #stemcellresearch #cellbioprocessing #scientificconference #OGM #Bionano

🎉 We are thrilled to announce the successful installation and operation of our Optical Genome Mapping system by Bionano Genomics. From ordering the instrument to obtaining our first results, it took just 27 days – a remarkable achievement! This success wouldn't have been possible without the incredible support from Garuda Therapeutics operations, finance, computational biology, R&D Scientists and IT departments. A special shoutout to the Bionano Genomics business development ( Zach Hrabosky ), field application scientists ( Andrew Owens ) and engineers (@steven haering) for their invaluable assistance. The data looks awesome, and we couldn’t be more excited about the possibilities this opens up for our R&D. We did it! Cheers to everyone involved! Finally, thanks to Bionano for the Italian food! 🥂 #Genomics #OpticalGenomeMapping #BionanoGenomics #TeamWork #Innovation #GarudaTherapeutics

COM:BIONANO

Bionano

Last Close

0.22

22/11 21:00

Market Cap

22.85M

Beta: -

Volume Today

2.92M

Avg: -